163810-26-2

Basic information

• Product Name: (R)-4-BENZYL-3-(4-METHYL-PENTANOYL)-OXAZOLIDIN-2-ONE
• Synonyms: 3-(3'-ISOPROPYL-1-OXOPROPYL)-4(R)-(1-PHENYLMETHYL)-2-OXAZOLIDINONE;3-(3-ISOPROPYL-1-OXOPROPYL)-4(R)-(1-PHENYLMETHYL)-2-OXAZOLIDINONE;(R)-4-BENZYL-3-(4-METHYL-PENTANOYL)-OXAZOLIDIN-2-ONE;2-Oxazolidinone, 3-(4-methyl-1-oxopentyl)-4-(phenylmethyl)-, (4R)-
• CAS NO: 163810-26-2
• Molecular Formula: C₁₆H₂₁NO₃
• Molecular Weight: 275.34
• Mol File: 163810-26-2.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 424.9 °C at 760 mmHg
• Flash Point: 210.7 °C
• Appearance: /
• Density: 1.131g/cm³
• Vapor Pressure: 2E-07mmHg at 25°C
• Refractive Index: 1.537
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (R)-4-BENZYL-3-(4-METHYL-PENTANOYL)-OXAZOLIDIN-2-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-4-BENZYL-3-(4-METHYL-PENTANOYL)-OXAZOLIDIN-2-ONE(163810-26-2)
• EPA Substance Registry System: (R)-4-BENZYL-3-(4-METHYL-PENTANOYL)-OXAZOLIDIN-2-ONE(163810-26-2)

Safety Data

• Hazardous Substances Data: 163810-26-2(Hazardous Substances Data)

Usage

General Description

"(R)-4-Benzyl-3-(4-methyl-pentanoyl)-oxazolidin-2-one" is a chemical compound with the molecular formula C19H23NO3. It is a chiral oxazolidinone derivative, which means it contains a cyclic five-membered ring that contains both oxygen and nitrogen atoms. (R)-4-BENZYL-3-(4-METHYL-PENTANOYL)-OXAZOLIDIN-2-ONE has potential applications in the field of organic synthesis, specifically in the creation of pharmaceuticals and agrochemicals. Its molecular structure and chiral nature make it a valuable building block for the synthesis of various complex organic compounds. Additionally, its benzyl and pentanoyl substituents give it unique chemical properties that make it useful for a wide range of synthetic applications. Further research and development of this compound may lead to its utilization in the creation of new drugs and agrochemical products.

InChI:InChI=1/C16H21NO3/c1-12(2)8-9-15(18)17-14(11-20-16(17)19)10-13-6-4-3-5-7-13/h3-7,12,14H,8-11H2,1-2H3/t14-/m1/s1

Upstream product

• 38136-29-7 4-methylvaleroyl chloride 
• 40217-17-2 (R)-4-(phenylmethyl)-2-oxazolidinone 
• 646-07-1 4-Methylpentanoic acid 

Downstream Products

• 198641-79-1 (S)-2-(4-tert-Butyl-benzyl)-4-methyl-pentan-1-ol 
• 503066-44-2 (R)-4-benzyl-3-[(S)-2-(benzyloxymethyl)-4-methylvaleroyl]oxazolidin-2-one 
• 561327-31-9 (R)-2-(benzyloxymethyl)-4-methylpentan-1-ol 
• 503066-45-3 (S)-2-(benzyloxymethyl)-1-iodo-4-methylpentane 
• 503066-37-3 (S)-[2-(benzyloxymethyl)-4-methylpentyl](chloromethyl)diphenylsilane 
• 561067-96-7 (S)-2-[[[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]diphenylsilanyl]methyl]-4-methylpentanal 
• 503066-38-4 2-[[[(S)-2-(hydroxymethyl)-4-methylpentyl]diphenylsilanyl]methyl]-2H-isoindole-1,3-dione 
• 503066-39-5 (S)-2-[[[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]diphenylsilanyl]methyl]-4-methylpentanoic acid 
• 503066-40-8 (S)-2-[(S)-2-[[(aminomethyl)diphenylsilanyl]methyl]-4-methylpentanoylamino]-4-methylpentanoic acid tert-butyl ester 
• 503066-42-0 (S)-2-[(S)-2-[[difluoro[(3-phenylpropionylamino)methyl]silanyl]methyl]-4-methylpentanoylamino]-4-methylpentanoic acid 
• 561067-32-1 2-[[[(S)-2-(benzyloxymethyl)-4-methylpentyl]diphenylsilanyl]methyl]-2H-isoindole-1,3-dione 
• 690674-38-5 (S)-2-[(S)-2-[[[(benzyloxycarbonylamino)methyl]diphenylsilanyl]methyl]-4-methylpentanoylamino]-4-methylpentanoic acid tert-butyl ester 
• 503066-41-9 (S)-2-[(S)-2-[[diphenyl[(3-phenylpropionylamino)methyl]silanyl]methyl]-4-methylpentanoylamino]-4-methylpentanoic acid tert-butyl ester 
• 561294-36-8 (S)-2-[(S)-2-[[[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]diphenylsilanyl]methyl]-4-methylpentanoylamino]-4-methylpentanoic acid tert-butyl ester 

Relevant articles and documents

Structural Revision of Baulamycin A and Structure-Activity Relationships of Baulamycin A Derivatives

Total synthesis of the proposed structure of baulamycin A was performed. The spectral properties of the synthetic compound differ from those reported for the natural product. On the basis of comprehensive NMR study, we proposed two other possible structur

Design and synthesis of the stabilized analogs of belactosin A with the unnatural cis-cyclopropane structure

The belactosin A analog 2a, having the unnatural cis-cyclopropane structure instead of the trans-cyclopropane structure in belactosin A, is a much more potent proteasome inhibitor than belactosin A. However, its cell growth inhibitory effect is rather lower than that expected from its remarkable proteasome inhibitory effect, probably due to its instability under cellular conditions. We hypothesized that the instability of 2a was due to chemical and enzymatic hydrolysis of the strained β-lactone moiety. Thus, to increase the stability of 2a by chemical modification, its analogs with a sterically more hindered β-lactone moiety and/or cyclopropylic strain-based conformational restriction were designed and synthesized, resulting in the identification of a stabilized analog 6a as a proteasome inhibitor with cell growth inhibitory effects. Our findings suggest that the chemical and biological stability of 2a is significantly affected by the steric hindrance around its β-lactone carbonyl moiety and the conformational flexibility of the molecule.

Fluoroalkenes as peptide isosteres: Ground state analog inhibitors of thermolysin

Tripeptide analogs of the form Cbz-GlyΨ[(Z/-CF=CH]LeuXaa (1, Xaa = Gly, Ala, Leu, Phe, and NH2) were synthesized to assess the ability of the fluoroalkene moiety to mimic a peptide linkage. These compounds are modest inhibitors of the zinc endo